|It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it.
This message has remained in place for seven days, so the article may be deleted without further notice.
Nominator: Please consider notifying the author/project:
Timestamp: 20170618002710 00:27, 18 June 2017 (UTC)
bNAber, abbreviated form for broadly neutralising antibodies electronic resource, is an integrated web resource focused on maintaining a comprehensive database of broadly neutralizing HIV-1 antibodies (bNAbs).
The discovery of broadly neutralizing HIV-1 antibodies (bNAbs) has provided an enormous boost to the HIV vaccine research and to entire immunology. The bNAber database at http://bNAber.org provides open, user friendly access to detailed data on the rapidly growing list of HIV bNAbs, including neutralization profiles, sequences, and three-dimensional structures (when available).
The goal of the bNAber database is to enable researchers in this field to easily compare and analyze available information on bNAbs thereby supporting efforts to design an effective vaccine for HIV/AIDS.
The bNAber database was created for the users who want to: (i) analyze in details sequence, 3D structure, neutralization profiles, escape mutations, etc. of anti HIV Abs; (ii) design new immunogens aiming to elicit broadly neutralizing antibodies; (iii) analyze 3D features of broad neutralization; (iv) sequences antibody genes in immunized animal/patient and tracks the development of the Ab genes leading to broad neutralization; (v) correlate features of sequence and structure of Abs with their ability to cross-neutralize. The resource could be of interest to researchers developing vaccines to other diseases, including Influenza, Hepatitis C, Dengue virus, and West_Nile viruses.